The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

A WOMAN who shed a whopping 6st in just nine months has shared the secret behind not pilling back all the pounds when eating out. Lucy Davies kickstarted her weight loss journey with the popular ...

Scientists have revealed a potential 'neurobiotic' sixth sense derived from direct communication between microorganisms and ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...